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ABSTRACT 
According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has 
reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active 
substance  desmedipham.  In  order  to  assess  the  occurrence  of  desmedipham  residues  in  plants,  processed 
commodities,  rotational  crops  and  livestock,  EFSA  considered  the  conclusions  derived  in the  framework of 
Directive 91/414/EEC as well as the European authorisations reported by Member States (incl. the supporting 
residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk 
assessment was carried out. Although no apparent risk to consumers was identified, some information required 
by  the  regulatory  framework  was  found  to  be  missing.  Hence,  the  consumer  risk  assessment  is  considered 
indicative only and all MRL proposals derived by EFSA still require further consideration by risk managers. 
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SUMMARY 
Desmedipham was included in Annex I to Directive 91/414/EEC on 01 March 2005, which is before 
the  entry  into  force  of Regulation (EC) No 396/2005 on 02 September 2008. EFSA is therefore 
required to provide a reasoned opinion on the review of the existing MRLs for that active substance in 
compliance  with  Article  12(2)  of  the  aforementioned  regulation.  In  order  to  collect  the  relevant 
pesticide residues data, EFSA asked Finland, as the designated rapporteur Member State (RMS), to 
complete the Pesticide Residues Overview File (PROFile). The requested information was submitted 
to EFSA on 25 January 2010 and, after having considered several comments made by EFSA, the RMS 
provided on 06 September 2011 a revised PROFile. 
Based  on  the  conclusions  derived  in  the  framework  of  Directive  91/414/EEC  and  the  additional 
information provided by the RMS, EFSA issued on 17 February 2014 a draft reasoned opinion that 
was circulated to Member States’ experts for consultation. Comments received by 18 April 2014 were 
considered in the finalisation of this reasoned opinion. The following conclusions are derived. 
The toxicological profile of desmedipham was evaluated in the framework of Directive 91/414/EEC, 
which resulted in an ADI and an ARfD being established at 0.03 mg/kg bw per d and 0.1 mg/kg bw, 
respectively. 
Primary crop metabolism of desmedipham was investigated following foliar application in sugar beet, 
hereby covering the root and tuber vegetables crop group. However, these studies are not fully reliable 
and new metabolism data are necessary in order to elucidate the metabolism of desmedipham in root 
and tuber vegetables. Moreover, the use of desmedipham by foliar application is also authorised on 
beet leaves, which do not belong to the aforementioned group. In order to cover all crops supported in 
the framework of this review, an additional metabolism study following foliar application on crops 
representing leafy vegetables is also required. According to the RMS, a new sugar beet metabolism 
study will be submitted in the framework of the renewal of the approval of the active substance under 
Regulation  (EC)  No  1107/2009  (January  2015).  Meanwhile,  a  tentative  residue  definition  for 
enforcement and risk assessment in plant commodities is defined as desmedipham only. Validated 
analytical methods for enforcement of the proposed residue definition are available with an LOQ of 
0.01 mg/kg in commodities with high water content. 
Regarding the magnitude of residues in primary crops, the available residues data were considered 
sufficient to derive MRL proposals as well as risk assessment values for sugar beet (root), beetroot 
and beet leaves (chard). However, as data on plants metabolism are insufficient, only tentative MRLs 
can be derived. Tentative MRLs were derived for feed crops (fodder beet (root and tops) and sugar 
beet (tops)) in view of the future need to set MRLs in feed items. 
The nature of residues during processing was not investigated. Nevertheless, as quantifiable residues 
of desmedipham are not expected in the treated crops and the chronic exposure does not exceed 10 % 
of the ADI, there is no need to investigate the effect of industrial and/or household processing. If 
robust  processing  factors  were  to  be  required  by  risk  managers,  in  particular  for  enforcement 
purposes, processing studies would be needed. 
Occurrence of desmedipham residues in rotational crops was investigated during the peer review. It 
can  be  concluded  that  significant  residues  in  rotational  crops  are  not  expected  (provided  that 
desmedipham is applied in compliance with the authorised European uses) and that a specific residue 
definition for rotational crops is not necessary. 
Based on the uses reported by the RMS, significant intakes were calculated for dairy ruminants, meat 
ruminants  and  pigs.  Metabolism  studies  in  lactating  ruminants  suffered  of  many  deficiencies. 
Nevertheless,  the  presence  of  many  metabolites  indicates  extensive  metabolism  of  parent Review of the existing MRLs for desmedipham 
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desmedipham,  involving  hydrolysis  and  conjugation.  Based  on  the  extraction  profiles,  it  can  be 
assumed that metabolism fate of desmedipham in ruminants is similar to the one in rat and findings in 
ruminants can be extrapolated to pigs. As, according to the available metabolism studies, residue 
levels in ruminant and pig commodities are expected to be negligible, a default residue definition for 
enforcement  and  risk  assessment  in  ruminant  and  pig  matrices  can  be  proposed  as  parent 
desmedipham only. Validated analytical methods for enforcement of the proposed residue definition 
are available with an LOQ of 0.05 mg/kg but a confirmatory method is still required. Furthermore, 
MRLs  and  risk  assessment  values  for  the  relevant  commodities  in  ruminants  and  pigs  can  be 
established at the LOQ level. These MRLs can only be tentatively derived but, considering the low 
residue expected in animal tissue, for the time being new ruminant metabolism studies are desirable 
only. Nevertheless, EFSA highlights that, if in the future new uses leading to residues above the LOQ 
in  animal  commodities  will  be  granted,  the  proposed  formal  residue  definition  will  need  to  be 
reconsidered and more data on animal metabolism will be required. For poultry matrices, neither a 
residue  definition,  nor  MRLs  or  risk  assessment  values  are  necessary,  as  there  is  no  significant 
exposure of poultry to desmedipham residues. 
Chronic and acute consumer exposure resulting from the MRLs derived in the framework of this 
review  was  calculated  using  revision  2  of  the  EFSA  PRIMo.  The  highest  chronic  exposure 
represented 8.2 % of the ADI (British children) and the highest acute exposure amounted to 6.2 % of 
the ARfD (milk and milk products). 
Based on the above assessment, EFSA does not  recommend inclusion of this active substance in 
Annex IV to Regulation (EC) No 396/2005. MRL recommendations were derived in compliance with 
the decision tree reported in Appendix D (see summary table). None of the MRL values listed in the 
table  are  recommended  for  inclusion  in  Annex  II  to  the  Regulation  as  they  are  not  sufficiently 
supported by data; they therefore require further consideration by risk managers (see summary table 
footnotes for details). In particular, certain tentative MRLs or existing EU MRLs still need to be 
confirmed by the following data: 
  a confirmatory method for the determination of desmedipham in fat, meat, liver and kidney (a 
new method will be provided in the framework of the AIR - January 2015); 
  a new representative study investigating primary crop metabolism in root and tuber vegetables 
(a new study will be provided in the framework of the AIR - January 2015); 
  a representative study investigating primary crop metabolism in leafy vegetables. 
If the above reported data gaps are not addressed in the future, Member States are recommended to 
withdraw or modify the relevant authorisations at national level. 
Minor deficiencies were also identified in the assessment but they are not expected to impact either on 
the validity of the MRLs derived or on the national authorisations. The following data are therefore 
considered desirable but not essential: 
  at least two trials in each zone complying with the northern and southern outdoor GAPs on 
sugar beet root, fodder beet root and beetroot, where residues are analysed according to the 
enforcement LOQ (0.01 mg/kg) (new trials will be provided in the framework of the AIR - 
January 2015); 
  at least two trials in each zone complying with the northern and southern outdoor GAPs on 
sugar  beet  tops,  fodder  beet  tops  and  beet  leaves  (chard),  where  residues  are  analysed 
according  to  the  enforcement  LOQ  (0.01  mg/kg)  (new  trials  will  be  provided  in  the 
framework of the AIR - January 2015); Review of the existing MRLs for desmedipham 
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  the missing information on the storage conditions of the samples from the concerned residue 
trials (this information will be provided in the framework of the AIR - January 2015); 
  new appropriate ruminant metabolism studies. 
SUMMARY TABLE 
Code 
number 
Commodity  Existing EU 
MRL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
Enforcement residue definition: desmedipham 
213010  Beetroot  0.05  0.05  Further consideration needed 
(1) 
252030  Beet leaves (chard)  0.05  0.05  Further consideration needed 
(1) 
900010  Sugar beet (root)  0.1  0.05  Further consideration needed 
(1) 
1011010  Swine muscle  -  0.05*  Further consideration needed 
(1) 
1011020  Swine fat (free of lean meat)  -  0.05*  Further consideration needed 
(1) 
1011030  Swine liver  -  0.05*  Further consideration needed 
(1) 
1011040  Swine kidney  -  0.05*  Further consideration needed 
(1) 
1012010  Bovine muscle  -  0.05*  Further consideration needed 
(1) 
1012020  Bovine fat  -  0.05*  Further consideration needed 
(1) 
1012030  Bovine liver  -  0.05*  Further consideration needed 
(1) 
1012040  Bovine kidney  -  0.05*  Further consideration needed 
(1) 
1013010  Sheep muscle  -  0.05*  Further consideration needed 
(1) 
1013020  Sheep fat  -  0.05*  Further consideration needed 
(1) 
1013030  Sheep liver  -  0.0.5*  Further consideration needed 
(1) 
1013040  Sheep kidney  -  0.05*  Further consideration needed 
(1) 
1014010  Goat muscle  -  0.05*  Further consideration needed 
(1) 
1014020  Goat fat  -  0.05*  Further consideration needed 
(1) 
1014030  Goat liver  -  0.0.5*  Further consideration needed 
(1) 
1014040  Goat kidney  -  0.05*  Further consideration needed 
(1) 
1020010  Cattle milk  -  0.05*  Further consideration needed 
(1) 
1020020  Sheep milk  -  0.05*  Further consideration needed 
(1) 
1020030  Goat milk  -  0.05*  Further consideration needed 
(1) 
-  Other products of plant and 
animal origin 
-  -  Further consideration needed 
(2) 
(*):   Indicates that the MRL is set at the limit of analytical quantification. 
(1):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified; no CXL is available (combination E-I in Appendix D). 
(2):  There are no relevant authorisations or import tolerances reported at EU level; no CXL is available. Either a specific 
LOQ or the default MRL of 0.01 mg/kg may be considered (combination A-I in Appendix D). 
 
 Review of the existing MRLs for desmedipham 
 
EFSA Journal 2014;12(7):3803  5 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 5 
Background .............................................................................................................................................. 6 
Terms of reference ................................................................................................................................... 7 
The active substance and its use pattern .................................................................................................. 7 
Assessment ............................................................................................................................................... 8 
1.  Methods of analysis ......................................................................................................................... 8 
1.1.  Methods for enforcement of residues in food of plant origin ................................................. 8 
1.2.  Methods for enforcement of residues in food of animal origin .............................................. 9 
2.  Mammalian toxicology .................................................................................................................... 9 
3.  Residues  ......................................................................................................................................... 10 
3.1.  Nature and magnitude of residues in plant ........................................................................... 10 
3.1.1.  Primary crops  .................................................................................................................... 10 
3.1.2.  Rotational crops  ................................................................................................................ 14 
3.2.  Nature and magnitude of residues in livestock ..................................................................... 15 
3.2.1.  Dietary burden of livestock .............................................................................................. 15 
3.2.2.  Nature and magnitude of residues .................................................................................... 16 
4.  Consumer risk assessment ............................................................................................................. 19 
Conclusions and recommendations ........................................................................................................ 20 
Documentation provided to EFSA ......................................................................................................... 23 
References .............................................................................................................................................. 23 
Appendix A – Good Agricultural Practices (GAPs) .............................................................................. 25 
Appendix B – Pesticide Residues Intake Model (PRIMo)  ..................................................................... 26 
Appendix C – Existing EU maximum residue limits (MRLs) ............................................................... 28 
Appendix D – Decision tree for deriving MRL recommendations ........................................................ 31 
Appendix E – List of metabolites and related structural formula .......................................................... 33 
Abbreviations ......................................................................................................................................... 34 Review of the existing MRLs for desmedipham 
 
EFSA Journal 2014;12(7):3803  6 
BACKGROUND 
Regulation (EC) No 396/2005
4 establishes the rules governing the setting and the review of pesticide 
MRLs at  European level. Article 12(2)  of that regulation  stipulates  that EFSA shall provide  by 
01 September 2009 a reasoned opinion on the review of the existing MRLs for all active substances 
included in Annex I to  Directive 91/414/EEC
5 before  02 September 2008. As desmedipham was 
included in Annex I to the above mentioned directive on 01 March 2005, EFSA initiated the review of 
all existing MRLs for that active substance and a task with the reference number EFSA -Q-2008-524 
was included in the EFSA Register of Questions. 
According to the legal provisions, EFSA shall base its reasoned opinion in particular on the relevant 
assessment report prepared under Directive 91/414/EEC. It should be noted, however, that in the 
framework of Directive 91/414/EEC only a few representative uses are evaluated, while MRLs set out 
in Regulation (EC) No 396/2005 should accommodate all uses authorised within the E U, and uses 
authorised in third countries  that have a significant impact on international trade. The information 
included in the assessment report prepared under Directive 91/414/EEC is therefore insufficient for 
the assessment of all existing MRLs for a given active substance. 
In order to gain an overview of the pesticide residues data that have been considered for the setting of 
the existing MRLs, EFSA developed the Pesticide Residue Overview File (PROFile). The PROFile is 
an inventory of all pesticide residues data relevant to the risk assessment and MRL setting for a given 
active substance. This includes data on: 
  the nature and magnitude of residues in primary crops; 
  the nature and magnitude of residues in processed commodities;  
  the nature and magnitude of residues in rotational crops;  
  the nature and magnitude of residues in livestock commodities;  
  the analytical methods for enforcement of the proposed MRLs. 
Finland, the designated rapporteur Member State (RMS) in the framework of Directive 91/414/EEC, 
was asked to complete the PROFile for desmedipham. The requested information was submitted to 
EFSA on 25 January 2010 and subsequently checked for completeness. On 06 September 2011, after 
having clarified some issues with EFSA, the RMS provided a revised PROFile. 
A draft reasoned opinion was issued by EFSA on 17 February 2014 and submitted to Member States 
(MS) for commenting. All MS comments received by 18 April 2014 were considered by EFSA in the 
finalisation of the reasoned opinion. 
                                                       
4  Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue 
levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 
70, 16.3.2005, p. 1-16. 
5  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market . OJ L 
230, 19.8.1991, p. 1-32. Review of the existing MRLs for desmedipham 
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TERMS OF REFERENCE 
According to Article 12 of Regulation (EC) No 396/2005, EFSA shall provide a reasoned opinion on: 
  the inclusion of the active substance in Annex IV to the Regulation, when appropriate; 
  the necessity of setting new MRLs for the active substance or deleting/modifying existing MRLs 
set out in Annex II or III of the Regulation; 
  the inclusion of the recommended MRLs in Annex II or III to the Regulation; 
  the setting of specific processing factors as referred to in Article 20(2) of the Regulation. 
 
THE ACTIVE SUBSTANCE AND ITS USE PATTERN 
Desmedipham is the ISO common name for ethyl 3-phenylcarbamoyloxycarbanilate (IUPAC). 
NH C
NH C O
O
O
O
CH2 CH3
 
Desmedipham  belongs  to  the  group  of  carbanilate  herbicide  compounds.  Desmedipham  is  not  a 
systemic substance.  It acts  through the foliage  of emerged weeds and inhibits  the  photosynthetic 
electron transport at the photosystem II receptor site. 
Desmedipham  was  evaluated  in  the  framework  of  Directive  91/414/EEC  with  Finland  being  the 
designated Rapporteur Member State (RMS). The representative use supported for the peer review 
process was the outdoor treatment of sugar and fodder beets in both northern and southern Europe. 
Following the peer review a decision on inclusion of the active substance in Annex I to Directive 
91/414/EEC was published by means of Commission Directive 2004/58/EC
6, entering into force on 
01 March 2005. According to Regulation (EU) No 540/2011
7, desmedipham is deemed to have been 
approved under Regulation (EC) No 1107/2009
8. This approval is restricted to uses as herbicide only. 
As EFSA was not yet involved in the peer review of  desmedipham, a conclusion of EFSA on this 
active substance is not available. 
The  EU  MRLs  for  desmedipham  are  established  in  Annexes  II  and  IIIB  of  Regulation  (EC) 
No 396/2005.  All existing EU MRLs, which  are  established for the  parent compound only, are 
summarized in Appendix C to this document. CXLs for desmedipham are not available. 
For the purpose of this MRL review, the critical uses of desmedipham currently authorized within the 
EU, have been collected by the RMS and reported in the PROFile (see Appendix A).  They include 
early foliar treatments  on sugar beet  and  beetroot,  at the  maximum rate of  480 g as/ha, both in 
northern and southern Europe.  The RMS did not report any use authorised in third countries that 
might have a significant impact on international trade. 
                                                       
6  Directive  2004/58/EC  of  23  April  2004,  amending  Council  Directive  91/414/EEC  to  include  alpha-cypermethrin, 
benalaxyl, bromoxynil, desmedipham, ioxynil and phenmedipham as active substances. OJ L 120, 24.4.2004, p. 26-29. 
7  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 
of the European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1-
186. 
8  Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ 309, 
24.11.2009, p. 1-50. Review of the existing MRLs for desmedipham 
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ASSESSMENT 
EFSA  bases  its  assessment  on  the  PROFile  submitted  by  the  RMS,  the  evaluation  report 
accompanying the PROFile (Finland, 2010), the Draft Assessment Report (DAR) and its addenda 
prepared under Council Directive 91/414/EEC (Finland, 2000, 2002, 2003), and the Review Report on 
desmedipham (EC, 2004). The assessment is performed in accordance with the legal provisions of the 
Uniform Principles for the Evaluation of the Authorization of Plant Protection Products adopted by 
Commission Regulation (EU) No 546/2011
9 and the currently applicable guidance documents relevant 
for the consumer risk assessment of pesticide residues ( EC, 1996, 1997a-g, 2000, 2010a,b, 2011 and 
OECD, 2011). 
1.  Methods of analysis 
1.1.  Methods for enforcement of residues in food of plant origin 
During the peer review under Directive 91/414/EEC, an analytical method using LC-MS/MS was 
evaluated and validated for the determination of desmedipham and its metabolite EHPC
10 in plant 
matrices with an LOQ of 0.05 mg/kg for each compound in high water content commodities (sugar 
beet leaves and roots) (Finland, 2000). However, this method is validated for only one mass transition 
and cannot be considered highly specific according to  current guidance document (EC, 2010a) . 
Moreover data about linearity and specificity were not reported and no ILV was available. 
A  multi-residue DFG S19 method using GC -MS  was  also  evaluated but not  validated for the 
determination of  desmedipham  in plant matrices   (sugar beet root) as data abou t linearity and 
specificity were not reported and the number of tested samples  was not sufficient (Finland, 2000). Its 
ILV was evaluated and validated for the determination of desmedipham with an LOQ of 0.03 mg/kg 
in high water content commodities  (sugar beet root) (Finland, 2002). However, this method is not 
validated on three ion fragments and therefore cannot be considered highly specific according to the 
current guidance document on analytical methods (EC, 2010a). 
In addition, after Annex I inclusion, the RMS also evaluated a multi-residue DFG S19 method using 
LC-MS/MS  and its ILV, which were validated  for the determination of  desmedipham, and  its 
metabolite EHPC with an LOQ of 0.01 mg/kg for each compound in  high water content (sugar beet 
root), high fat content (oil seed rape), acidic (orange)  and dry commodities (wheat grain) (Finland, 
2010). However, this method is validated for only one mass transition and cannot be considered 
highly specific according to the  current guidance document on analytical m ethods (EC, 2010a). 
Validation data concerning the second mass transition is missing  but, according to the RMS, should 
be submitted in the framework of the renewal of the approval of the active substance under 
Regulation (EC) No 1107/2009 (January 2015). 
The multi-residue  QuEChERS method in combination with  HPLC-MS/MS, as described by CEN 
(2008) is also reported for analysis of the desmedipham only with an LOQ of 0.01mg/kg in high water 
content  commodities  (Table 1-1).  This method can be used as  a confirmatory method for the 
determination of desmedipham in high water content matrices. 
                                                       
9  Commission  Regulation  (EU)  No 546/2011  of  10 June  2011  implementing  Regulation  (EC)  No 1107/2009  of  the 
European Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection 
products. OJ L 155, 11.06.2011, p. 127-175. 
10 EHPC: ethyl (3-hydroxyphenyl)carbamate, see appendix E Review of the existing MRLs for desmedipham 
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Table 1-1:  Recovery  data  for  the  analysis  of  desmedipham  in  different  crop  groups  using  the 
QuEChERS method in combination with LC-MS/MS (EURL, 2014) 
Commodity group  Spiking levels 
(mg/kg) 
Recoveries  No of labs 
Mean (%)  RSD (%)  n 
High water content  0.01 
0.1 
86.8 
85.5 
3.3 
5.5 
6 
6 
1 
 
Hence it is concluded that desmedipham can be enforced in food of plant origin with a n LOQ of 
0.01 mg/kg in high water content commodities. 
1.2.  Methods for enforcement of residues in food of animal origin 
During the peer review under Directive 91/414/EEC, an analytical method using LC-MS/MS and its 
ILV were evaluated and validated for the determination of desmedipham and its metabolite EHPC in 
food of animal origin with an LOQ of 0.05 mg/kg for each compound in milk, meat, fat, liver, kidney 
and eggs (Finland, 2003). This method can be confirmed by HPLC/UVD method validated for the 
determination of desmedipham and its metabolite EHPC with LOQ for each compound of 0.02 mg/kg 
in  milk  (Finland,  2000).  However,  a  confirmatory  method  is  missing  for  the  determination  of 
desmedipham and its metabolite EHPC in fat, meat, liver and kidney and it is required. 
According to the RMS, an analytical method for the determination of desmedipham residue in food of 
animal matrices will be submitted in the framework of the renewal of the approval of the active 
substance under Regulation (EC) No 1107/2009 (January 2015). 
Hence it is concluded, that desmedipham can be enforced in food of animal origin with an LOQ of 
0.05 mg/kg in milk, meat, fat, liver and kidney. However, a confirmatory method is missing for the 
determination of desmedipham in fat, meat, liver and kidney and it is therefore required.  
2.  Mammalian toxicology 
The toxicological assessment of desmedipham was peer reviewed under Directive 91/414/EEC and 
toxicological  reference  values  were  established  by  the  European  Commission  (2004).  These 
toxicological reference values are summarized in Table 2-1. 
Table 2-1:  Overview of the toxicological reference values 
  Source  Year  Value  Study relied upon  Safety 
factor 
Desmedipham 
ADI  EC  2004  0.03 mg/kg bw per d  2 year, rat  100 
ARfD  EC  2004  0.1 mg/kg bw  80-day study in dog  
Developmental toxicity in rat 
100 
 Review of the existing MRLs for desmedipham 
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3.  Residues 
3.1.  Nature and magnitude of residues in plant 
3.1.1.  Primary crops 
3.1.1.1.  Nature of residues 
The metabolism of desmedipham was investigated for foliar application on root and tuber vegetables 
(sugar  beet),  using  m-aminophenol  moiety  ring-  or  phenoxy  ring-labelled  desmedipham  (Finland, 
2000). The characteristics of these studies are summarized in Table 3-1. 
Table 3-1:  Summary of available metabolism studies in plants 
Group  Crop  Label 
position 
Application and sampling details 
Method,  
F or G 
(a) 
Rate  No  Sampling 
(DAT) 
Remarks 
Root and tuber 
vegetables 
Sugar beet  EPC
(b) ring   Foliar by 
microsyringe
(d), 
G 
0.5 g/plant  1  0, 5, 10, 
15, 30, 60, 
and 90  
- 
EPC or 
PC
(c) ring 
Foliar spraying, 
G 
1 kg a.s./ha  1  0, and 7, 
28 and ca 
120 
- 
5 kg a.s./ha 
(a):  Outdoor/field application (F) or glasshouse/protected/indoor application (G). 
(b):  EPC = ethyl 3-[U-
14C] phenylcarbomoyloxyphenylcarbamate. 
(c):  PC = ethyl 3-phenylcarbomoyloxy-[U-
14C] phenylcarbamate. 
(d):  Treatment was performed at the 4-leaf stage. 
 
In the first study, the highest TRR was identified in leaf (64.1 % AR at final harvest). In root, the 
radioactivity was low but increased continuously throughout the study, reaching a maximum of 3.8 % 
of the AR 60 days after application (DAT). Compounds were only identified in leaf rinse. At final 
harvest (90 DAT), the main component of the residue was the metabolite EHPC (49.4 % TRR) while 
parent  desmedipham  and  m-aminophenol
11accounted  for  27.1  %  and  for 11.5  %  of the  TRR, 
respectively. Some other components were identified, but they remained below 10  % of the TRR. 
From the second study, no relevant results can be reported since metabolites were only quantified but 
not identified. It can be highlighted that, in root and shoot at harvest,  some metabolites represented 
more than 10 % of the TRR (up to 17.4  % TRR). Moreover, no information was given on the TRR 
ratio in each crop part. 
The  decreasing  levels of parent  desmedipham  during the course of the studies  suggest  a  slow 
degradation of desmedipham, through cleavage, resulting in the formation of polar components. In 
particular, metabolite EHPC (also encountered in rat metabolism) was found at high levels in  sugar 
beet leaves. EHPC can be conjugated with sugars. Direct conjugation of parent compound c an also 
occur. 
                                                       
11 m-aminophenol: 3-aminophenol, see appendix E. Review of the existing MRLs for desmedipham 
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EFSA is of the opinion that both studies showed several deficiencies. Indeed, the first study, dated 
1972, was not performed according to the GLP principles. Moreover, from the reported application 
method (“by microsyringe“) and dose rate (in g/plant), it is not possible to ensure that the authorised 
European uses on beets and beet leaves are covered. In addition, no relevant results could be reported 
from the second study. Despite the poor quality of the first study, it is likely that residues in roots 
would be negligible. In leaves, metabolite EHPC was found at higher rates than parent compound and 
increased from the application to the harvest. This observation does not correspond to the results of 
the residue trials on sugar beet reported in the monograph (Finland, 2002), where residue levels of 
metabolite EHPC in leaves and roots were lower than the parent compound at 0 day PHI and both 
compounds were undetectable at harvest.  
Therefore, EFSA concluded that a robust residue definition cannot be established on the basis of the 
available metabolism studies. Consequently, new metabolism data covering the currently authorised 
European uses, representative for root and tuber vegetables and leafy vegetables metabolism groups, 
are required. According to the RMS, a new sugar beet metabolism study will be submitted in the 
framework  of  the  renewal  of  the  approval  of  the  active  substance  under  Regulation  (EC)  No 
1107/2009  (January  2015).  Meanwhile,  a  tentative  residue  definition  for  enforcement  and  risk 
assessment in plant commodities is defined as desmedipham only. Validated analytical methods for 
enforcement of the proposed residue definition are available (see also Section 1.1). 
3.1.1.2.  Magnitude of residues 
According to the RMS, the active substance desmedipham is authorised in northern and southern 
Europe for foliar application in different crops, only under outdoor conditions (see Appendix A). To 
assess  the  magnitude  of  desmedipham  residues  resulting  from  these  GAPs,  EFSA  considered  all 
residue trials reported in the PROFile, including residue trials evaluated in the framework of the peer 
review (Finland, 2000, 2002, 2003). All available residues trials that, according to the RMS, comply 
with the authorised GAPs, are summarized in Table 3-2. 
The number of residues trials and extrapolations were evaluated in accordance with the European 
guidelines on comparability, extrapolation, group tolerances and data requirements for setting MRLs 
(EC, 2011). For the reported GAPs, sufficient trials are available to derive tentative MRLs and risk 
assessment values. The following considerations were made by EFSA: 
  For sugar beet root, fodder beet root and beetroot, the number of residue trials supporting the 
outdoor GAPs is not compliant with the data requirements for these crops. However, the 
reduced number of residues trials is considered acceptable for deriving MRL proposals in this 
case because results were all below the LOQ and a no residue situation is expected (see also 
Section 3.1.1.1). Nevertheless, at least two trials for each zone where residues are analysed 
according to the enforcement LOQ (0.01 mg/kg) would be desirable. According to the RMS, 
these studies will be submitted in the framework of the renewal of the approval of the active 
substance under Regulation (EC) No 1107/2009 (January 2015). 
  For sugar beet tops, fodder beet tops and beet leaves (chard), the number of residue trials 
supporting the outdoor GAPs is compliant with the data requirements for these crops, as they 
are either feed items or minor crops. Nevertheless, at least two trials for each zone where 
residues are analysed according to the enforcement LOQ (0.01 mg/kg) would be desirable. 
According to the RMS, these studies will be submitted in the framework of the renewal of the 
approval of the active substance under Regulation (EC) No 1107/2009 (January 2015). 
The potential degradation of residues during storage of the residues trial samples was also assessed. In 
a study evaluated by the RMS after the peer review process, storage stability of desmedipham and its 
metabolite EHPC was demonstrated for a period of 24 months at -18 °C in commodities with high Review of the existing MRLs for desmedipham 
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water content (sugar beet root). It should be noted that, in sugar beet leaves, desmedipham was also 
stable  for  24  months  but  its  metabolite  EHPC,  for  1  month  only  (Finland,  2010).  The  storage 
conditions were reported by the RMS only for some of the available residues trials: samples were 
stored frozen for 51 to 471 days (ca. up to 16 months) which is less than the demonstrated storage 
stability period. As all residue results were below the LOQ, information on the storage conditions of 
the samples from the other trials is desirable only. According to the RMS, this information will be 
available in the data submitted in the framework of the renewal of the approval of the active substance 
under Regulation (EC) No 1107/2009 (January 2015). 
Consequently, the available residues data are considered sufficient to derive MRL proposals as well 
as risk assessment values for sugar beet (root), beetroot and beet leaves (chard). However, as data on 
plants metabolism are insufficient, only tentative MRLs can be derived. Tentative MRLs were also 
derived for feed crops (fodder beet (root and tops), sugar beet (tops)) in view of the future need to set 
MRLs in feed items. Review of the existing MRLs for desmedipham 
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Table 3-2:  Overview of the available residues trials data  
Commodity  Residue 
region 
(a) 
Outdoor
/Indoor 
Individual trial results (mg/kg)  Median 
residue 
(mg/kg) 
(b) 
Highest 
residue 
(mg/kg) 
(c) 
MRL 
proposal 
(mg/kg) 
Median 
CF 
(d) 
Comments 
Enforcement 
(Desmedipham) 
Risk assessment 
(Desmedipham) 
Sugar beet 
(root) 
Beetroot 
Fodder beet 
(root) 
NEU  Outdoor  6 × <0.05  6 × <0.05  0.05  0.05  0.05 
(e) 
(tentative) 
1.0  Trials on sugar beet compliant 
with GAP. Extrapolation to 
beetroot and fodder beet possible. 
SEU  Outdoor  5 × <0.05  5 × <0.05 
 
 
0.05  0.05  0.05 
(e) 
(tentative) 
1.0  Trials on sugar beet compliant 
with GAP. Extrapolation to 
beetroot and fodder beet possible.  
Sugar beet 
(tops) 
Fodder beet 
(tops) 
Beet leaves 
(chard) 
NEU  Outdoor  6 × <0.05  6 × <0.05  0.05  0.05  0.05 
(e) 
(tentative) 
1.0  Trials on sugar beet compliant 
with GAP. Extrapolation to fodder 
beet and beet leaves (chard) 
possible.  
SEU  Outdoor  5 × <0.05  5 × <0.05  0.05  0.05  0.05 
(e) 
(tentative) 
1.0  Trials on sugar beet compliant 
with GAP. Extrapolation to fodder 
beet possible.  
Use on beet leaves not authorised. 
(a):  NEU (Northern and Central Europe), SEU (Southern Europe and Mediterranean), EU (i.e outdoor use) or Import (country code) (EC, 2011). 
(b):  Median value of the individual trial results according to the enforcement residue definition. 
(c):  Highest value of the individual trial results according to the enforcement residue definition. 
(d):  The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual conversion factors for each residues trial. 
(e):  These MRLs can only be tentatively derived due to the data gaps for plant metabolism highlighted in Section 3.1.1.1. 
 Review of the existing MRLs for desmedipham 
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3.1.1.3.  Effect of industrial processing and/or household preparation 
As  quantifiable  residues  of  desmedipham  are  not  expected  in  the  treated  crops  and  the  chronic 
exposure does not exceed 10 % of the ADI (see also Section 4), there is no need to investigate the 
effect of industrial and/or household processing. If robust processing factors were to be required by 
risk managers, in particular for enforcement purposes, processing studies would be needed. 
3.1.2.  Rotational crops 
3.1.2.1.  Preliminary considerations 
All crops under consideration may be grown in rotation. According to the soil degradation studies 
evaluated  in  the  framework  of  the  peer  review,  DT90field  value  of  desmedipham  ranges  between 
18.5 - 40 days which is below the trigger value of 100 days. However, it should be noted that DT90lab 
value of desmedipham ranges between 18 - 714 days (EC, 2004). Furthermore, DT90 value of the 
major soil metabolite EHPC was not investigated. According to the European guidelines on rotational 
crops (EC, 1997c) and in absence of sufficient information on the degradation rate of desmedipham 
and its main soil metabolites in soil, further investigation of residues in rotational crops are required.  
3.1.2.2.  Nature and magnitude of residues 
The metabolism of desmedipham in rotational crops – lettuce, radish and wheat – has been evaluated 
in  the  framework  of  the  peer  review  (Finland,  2000).  Three  confined  rotational  crop  studies 
investigating  the  nature  of  residues  following  different  plant-back  intervals  are  available.  The 
characteristics of these studies are summarised in Table 3-3. 
Table 3-3:  Summary of available metabolism studies in rotational crops 
Crop group  Crop  Label 
position 
Application and sampling details 
Method,  
F or G 
(a) 
Rate 
(kg 
a.s./ha) 
Sowing 
intervals 
(DAT) 
Harvest 
Intervals 
Remarks 
Leafy 
vegetables  
Lettuce  EPC
(b) or PC
(c) 
ring 
G  2.5  30, 120, 
365 
Immature 
Mature 
 
Root and tuber 
vegetables 
Radish  EPC
(b) or PC
(c) 
ring 
G  2.5  30, 120, 
365 
Immature 
Mature 
 
Cereals  Wheat  EPC
(b) or PC
(c) 
ring 
G  2.5  30, 120, 
365 
Immature 
Mature 
 
(a):  Outdoor/field application (F) or glasshouse/protected/indoor application (G). 
(b):  EPC = ethyl 3-[U-
14C] phenylcarbomoyloxyphenylcarbamate. 
(c):  PC = ethyl 3-phenylcarbomoyloxy-[U-
14C] phenylcarbamate. 
 
In the analysed commodities, maximum residues at mature stages were 0.23 mg eq./kg in the 30 day 
plot (wheat forage), 0.09 mg eq./kg in the 120 day plot (wheat straw) and 0.04 mg eq./kg in the 365 
day plot (wheat straw). Residues in all other raw commodities were 0.04 mg eq./kg or below in the 
120 day plot and 0.02 mg eq./kg or below in the 365 day plot. Uptake of residues into rotational crops 
was low at all sampling times, declining rapidly as the planting interval increased. This was due to 
both a decrease in the total residue in soil with time and a rapid decline in the extractability of the 
remaining residues. Review of the existing MRLs for desmedipham 
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Considering the overdosing factor of the above study (around 5 times the dose level of the authorised 
European GAPs) and that desmedipham was applied on bare soil (interception of desmedipham by 
plants is expected in practice), it can be concluded that desmedipham residue levels in rotational 
commodities  are  not  expected  to  exceed  0.01  mg/kg  (provided  that  desmedipham  is  applied  in 
compliance  with  the  GAPs  reported  in  Appendix  A)  and  that  a  specific  residue  definition  for 
rotational crops is not necessary.  
3.2.  Nature and magnitude of residues in livestock 
3.2.1.  Dietary burden of livestock 
Desmedipham is authorised for use on several crops that might be fed to livestock. The median and 
maximum dietary burdens were therefore calculated for different groups of livestock using the agreed 
European methodology (EC, 1996). The input values for all relevant commodities have been selected 
according to the recommendations of JMPR (FAO, 2009) and are summarized in Table 3-4.  
Table 3-4:  Input values for the dietary burden calculation  
Commodity  Median dietary burden  Maximum dietary burden 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk assessment residue definition: desmedipham 
Sugar beet leaves  0.05  Median residue  0.05  Highest residue 
Fodder beet leaves  0.05  Median residue  0.05  Highest residue 
Sugar beets  0.05  Median residue  0.05  Highest residue 
Fodder beets  0.05  Median residue  0.05  Highest residue 
 
The results of the calculations are reported in Table 3-5. The calculated dietary burdens were found to 
exceed  the  trigger  value  of  0.1  mg/kg  DM   for  all  groups  of  livestock  except  poultry.  Further 
investigation of residues is therefore required in these groups of livestock. 
Table 3-5:  Results of the dietary burden calculation 
  Median 
dietary burden 
(mg/kg bw per d) 
Maximum 
dietary burden 
(mg/kg bw per d) 
Highest 
contributing 
commodity 
Max dietary 
burden 
(mg/kg DM) 
Trigger 
exceeded
(Y/N) 
Risk assessment residue definition: desmedipham  
Dairy ruminants  0.0061  0.0061  Sugar beet leaves  0.17  Y 
Meat ruminants  0.0104  0.0104  Sugar beets  0.24  Y 
Poultry  0.0032  0.0032  Sugar beets  0.05  N 
Pigs  0.0091  0.0091  Sugar beets  0.23  Y 
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3.2.2.  Nature and magnitude of residues 
The  nature  of  desmedipham  residues  in  commodities  of  animal  origin  was  investigated  in  the 
framework  of  Directive  91/414/EEC  (Finland,  2000,  2002,  2003).  Reported  metabolism  studies 
include two studies in lactating goats and two studies in laying hens (although not required) using 
m-aminophenol moiety ring- or phenoxy ring- labelled desmedipham. The characteristics of these 
studies are summarized in Table 3-6. 
Table 3-6:  Summary of available metabolism studies in livestock 
Group  Species  Label 
position 
No of 
animal 
Application details  Sample details 
Rate  Duration 
(days) 
Commodity  Time 
Lactating 
ruminants 
Cow  EPC
(a) 
ring 
1  0.4 mg/kg 
bw per d 
4  Milk  Twice daily 
Urine and 
faeces 
Once, after final 
dose prior to 
sacrifice 
Blood  Prior dosing, 
and 0.5, 1, 2, 3, 
4, 6, 8, 12 and 
24 h after initial 
dose and prior 
to sacrifice 
Tissues  At sacrifice 
PC
(b) ring  1  0.35 mg/kg 
bw per d 
7  Milk  Twice daily 
Excreta  Daily 
Tissues  At sacrifice 
Laying 
poultry 
Hens  EPC
(a) 
ring 
6  1.5 
mg/hen/d 
10  Eggs  Daily 
Excreta  Daily 
Tissues  At sacrifice 
PC
(b) ring  5  1.5 
mg/hen/d 
14  Egg  Twice daily 
Excreta  Daily 
Blood  At sacrifice 
Tissues  At sacrifice 
(a):  EPC = ethyl 3-[U-
14C] phenylcarbomoyloxyphenylcarbamate. 
(b):  PC = ethyl 3-phenylcarbomoyloxy-[U-
14C] phenylcarbamate. 
 
Lactating  cows  were  dosed  with  0.4  mg/kg  bw  per  d  of  EPC-labelled  desmedipham  and 
0.35 mg/kg bw per d of PC-labelled desmedipham, corresponding to 35 - 40 times the exposure of 
meat ruminants. Studies demonstrate that transfer of residues to milk and tissues is significant.  
In  both  studies,  radioactivity  was  extensively  excreted  via  urine  (81  %  AR  in  the  study  with 
PC-labelled  desmedipham).  In  the  study  performed  with  EPC-labelled  desmedipham,  the  highest 
residue levels were found in kidney (0.307 mg eq./kg) and milk (0.187 mg eq./kg, 5h after the last 
dose);  in  muscle,  residues  were  undetectable  and  in  the  other  matrices  they  ranged  from 
0.019 mg eq./kg (omental fat) to 0.040 mg eq./kg (liver). Following administration of PC-labelled 
desmedipham,  the  highest  residue  levels  were  observed  in  liver  (1.181  mg  eq./kg)  and  kidney Review of the existing MRLs for desmedipham 
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(0.634 mg  eq./kg);  in  the  other  matrices,  they  ranged  from  0.037  mg  eq./kg  (omental  fat)  to 
0.157 mg eq./kg (milk, 80h after the 1
st dose). It can be observed that the residue levels were about 
2 to 30 times higher in internal organs, fat, blood and plasma in the cow treated with PC-labelled 
desmedipham than in the cow treated with EPC-labelled desmedipham. Residue levels in milk were 
comparable in both studies. 
The extraction yields from the EPC-labelled desmedipham study were not reported, while, for the PC-
labelled desmedipham study, they were acceptable, ranging from 69.4 % TRR (renal fat) to 95.5 % 
TRR  (milk).  In  the  EPC-labelled  desmedipham  study,  metabolite  EHPC  constituted  the  most 
important  component  of  the  residue  in  every  matrix  where  residues  were  sufficiently  high  to  be 
identified  (75.1  %  TRR  in  milk,  76.7  %  TRR,  in  kidney and 13.6 % TRR in liver). Metabolite 
3-acetamidophenol
12 was detected at low levels in all tissues. In the PC-labelled desmedipham study, 
4-acetamidophenol
13  was the main identified metabolite in  all samples  analysed  (64.3  % TRR, 
0.1 mg eq./kg in milk, 24.4 % TRR, 0.16 mg eq./kg in kidney, 23.7 % TRR, 0.02 mg eq./kg in muscle, 
23.1  %  TRR,  0.27 mg eq./kg  in liver, 22 %  TRR,  0.01 mg eq./kg  in renal fat, 20.2  %  TRR, 
<0.01 mg eq./kg  in omental fat ). 4-aminophenol
14  was also detected in  all  tissues, being above 
10 % TRR in kidney (15.6 % TRR, 0.01 mg eq./kg) and omental fat (14.3 % TRR, <0.01 mg eq./kg). 
Several unknown component s  were also detected in   tissues, amounting up to 25.8 % TRR   or 
0.3 mg eq./kg (liver). Indeed, complete identification of the radioactive residues was not performed in 
this study as only two reference compounds were used: 4-acetamidophenol and 4-aminophenol. In 
particular, samples were not  analysed for N-(phenyl)methyl carbamate
15, one of the main PC -ring 
pathway metabolites in rat. Nevertheless, based on the extraction profiles, it can be assumed that the 
unidentified components are probably conjugates and reaction products with endogenous material.  
Laying hens were dosed with approximately 1 mg/kg bw per d of desmedipham in both studies, which 
is about 300 times the exposure of poultry. Studies demonstrat e that transfer of residues to  eggs and 
tissues is significant.  
Considering the two studies, h ighest residue levels were found in   egg yolk (0.654  mg/kg), liver 
(0.402 mg/kg) and skin (0.399 mg/kg). As in the studies in cow, the levels of PC labelled resi dues 
were significantly higher than with the EPC labelled. 
From the EPC-labelled desmedipham study, tissue residues were very low (<0.008 mg/kg). This can 
be explained by the fast elimination of the radioactivity observed: at least 85 % of each daily dose 
was  excreted  during  the  subsequent  24h.  The  highest  TRR  was  identified  in  egg  yolk 
(0.05 - 0.06 mg/kg),  where  metabolites  3 -aminophenol  and  EHPC  were  the  major  components 
representing 47.5 % and 26.5 % of total residue, respectively. F rom the PC-labelled desmedipham 
study, highly polar radioactive compounds were the major components in most tissues.   Other 
metabolites were identified but were all present in very small amounts (<0.011 % of the administrated 
dose). 
In the metabolism studies on both ruminant and poultry, the presence of  many metabolites indicates 
extensive metabolism involving hydrolysis and conjugation of parent desmedipham.  The general 
metabolic pathways in rodents and ruminants seem to be comparable   although the deficienc ies 
identified in the studies; the findings in ruminants can therefore be extrapolated to pigs. 
Based on the above finding s  and according to the  authorised European  uses,  neither  a residue 
definition, nor MRLs or risk assessment values are necessary for poultry matrices. 
                                                       
12 3-acetamidophenol: N-(3-hydroxyphenyl)acetamide, see appendix E. 
13 4-acetamidophenol: N-(4-hydroxyphenyl)acetamide, see appendix E. 
14 4-aminophenol, see appendix E. 
15 N-(phenyl)methyl carbamate: methyl phenylcarbamate, see appendix E. Review of the existing MRLs for desmedipham 
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For  ruminants,  despite  the  deficiencies  of  the  available  studies,  metabolites  EHPC  and  4-
acetamidophenol seem to be the major components of the residue in animal tissues. Nevertheless, as 
4-acetamidophenol is a common metabolite formed from pendimethalin, EHPC is considered as a 
representative marker of the residue in products of animal origin. However, according to the available 
metabolism studies, after exposure to the maximum dietary burden (about 40 times lower than the 
application dose rate of the metabolism studies; see also Section 3.2.1), residue levels in ruminant and 
pig commodities are expected to remain below the enforcement LOQ of 0.05 mg/kg. Therefore, a 
default residue definition for enforcement and risk assessment in ruminant and pig matrices can be 
proposed as parent desmedipham only. Validated analytical methods for enforcement of the proposed 
residue definition are available but a confirmatory method is still required (see also Section 1.1). 
Furthermore, no livestock feeding study is needed and MRLs and risk assessment values for the 
relevant commodities in ruminants and pigs can be established at the LOQ level. These MRLs can 
only be tentatively derived, due to the data gaps identified in Section 1.2 and 3.1.1. 
Considering  that  no  residues  are  expected  in  ruminant  matrices  with  regards  to  the  currently 
authorized European uses, new ruminant metabolism studies are desirable only. Nevertheless, EFSA 
highlights that, if new uses leading to residues above the LOQ in animal commodities will be granted 
in the future, the proposed formal residue definition will need to be reconsidered and more data on 
animal metabolism will be required.  
Log  Pow  of  desmedipham  (3.39) is higher than 3 (Finland, 2000). Nevertheless, according to the 
results of the livestock metabolism studies (desmedipham was never found in any tissues),  EFSA 
concludes that the residue in commodities of animal origin is not fat soluble. 
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4.  Consumer risk assessment 
Chronic and acute exposure calculations for all crops reported in the framework of this review were 
performed using revision 2 of the EFSA Pesticide Residues Intake Model (PRIMo) (EFSA, 2007). 
Input values for the  exposure  calculations were derived in compliance with Appendix D and are 
summarized in Table 4-1. The tentative median and highest residue values selected for chronic and 
acute intake calculations are based on the residue levels in the raw agricultural commodities reported 
in  Section  3.  The  contributions  of  other  commodities,  for  which  no  GAP  was  reported  in  the 
framework of this review, were not included in the calculation.  
Table 4-1:  Input values for the consumer risk assessment 
Commodity  Chronic risk assessment  Acute risk assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk assessment residue definition: desmedipham 
Beetroot  0.05  Median residue 
(tentative)
 (a) 
0.05  Highest residue 
(tentative)
 (a) 
Beet leaves (chards)  0.05  Median residue 
(tentative)
 (a) 
0.05  Highest residue 
(tentative) 
(a) 
Sugar beet (root)  0.05  Median residue 
(tentative) 
(a) 
0.05  Highest residue 
(tentative) 
(a) 
Swine meat  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Swine fat (free of lean 
meat) 
0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Swine liver  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Swine kidney  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Ruminant meat  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Ruminant fat  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Ruminant liver  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Ruminant kidney  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
Ruminant milk  0.05*  Median residue 
(tentative) 
(b) 
0.05*  Highest residue 
(tentative) 
(b) 
(*):  Indicates that the input value is proposed at the limit of analytical quantification. 
(a):  Use reported by the RMS is not fully supported by data but the risk assessment values derived in Section 3 are used for 
indicative exposure calculations. 
(b):  Dietary burden relevant to this commodity of animal origin, resulting from the GAPs reported by the RMS, is not fully 
supported by data; the risk assessment values derived in Section 3 are used for indicative exposure calculations. 
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The  calculated  exposures  were  compared  to  the  toxicological  reference  values  derived  for 
desmedipham (see Table 2-1); detailed results of the calculations are presented in Appendix B. The 
highest chronic exposure was calculated for British children, representing 8.2 % of the ADI, and the 
highest acute exposure was calculated for milk and milk products, representing 6.2 % of the ARfD. 
Based on the above calculations, for all crops authorised, major uncertainties remain due to the data 
gaps identified in Section 3, in particular with regard to the residue definition in plant commodities, 
but considering tentative MRLs in the exposure calculation did not indicate a risk to consumers. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
The toxicological profile of desmedipham was evaluated in the framework of Directive 91/414/EEC, 
which resulted in an ADI and an ARfD being established at 0.03 mg/kg bw per d and 0.1 mg/kg bw, 
respectively. 
Primary crop metabolism of desmedipham was investigated following foliar application in sugar beet, 
hereby covering the root and tuber vegetables crop group. However, these studies are not fully reliable 
and new metabolism data are necessary in order to elucidate the metabolism of desmedipham in root 
and tuber vegetables. Moreover, the use of desmedipham by foliar application is also authorised on 
beet leaves, which do not belong to the aforementioned group. In order to cover all crops supported in 
the framework of this review, an additional metabolism study following foliar application on crops 
representing leafy vegetables is also required. According to the RMS, a new sugar beet metabolism 
study will be submitted in the framework of the renewal of the approval of the active substance under 
Regulation  (EC)  No  1107/2009  (January  2015).  Meanwhile,  a  tentative  residue  definition  for 
enforcement and risk assessment in plant commodities is defined as desmedipham only. Validated 
analytical methods for enforcement of the proposed residue definition are available with an LOQ of 
0.01 mg/kg in commodities with high water content. 
Regarding the magnitude of residues in primary crops, the available residues data were considered 
sufficient to derive MRL proposals as well as risk assessment values for sugar beet (root), beetroot 
and beet leaves (chard). However, as data on plants metabolism are insufficient, only tentative MRLs 
can be derived. Tentative MRLs were derived for feed crops (fodder beet (root and tops) and sugar 
beet (tops)) in view of the future need to set MRLs in feed items. 
The nature of residues during processing was not investigated. Nevertheless, as quantifiable residues 
of desmedipham are not expected in the treated crops and the chronic exposure does not exceed 10 % 
of the ADI, there is no need to investigate the effect of industrial and/or household processing. If 
robust  processing  factors  were  to  be  required  by  risk  managers,  in  particular  for  enforcement 
purposes, processing studies would be needed. 
Occurrence of desmedipham residues in rotational crops was investigated during the peer review. It 
can  be  concluded  that  significant  residues  in  rotational  crops  are  not  expected  (provided  that 
desmedipham is applied in compliance with the authorised European uses) and that a specific residue 
definition for rotational crops is not necessary. 
Based on the uses reported by the RMS, significant intakes were calculated for dairy ruminants, meat 
ruminants  and  pigs.  Metabolism  studies  in  lactating  ruminants  suffered  of  many  deficiencies. 
Nevertheless,  the  presence  of  many  metabolites  indicates  extensive  metabolism  of  parent 
desmedipham,  involving  hydrolysis  and  conjugation.  Based  on  the  extraction  profiles,  it  can  be 
assumed that metabolism fate of desmedipham in ruminants is similar to the one in rat and findings in 
ruminants can be extrapolated to pigs. As, according to the available metabolism studies, residue Review of the existing MRLs for desmedipham 
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levels in ruminant and pig commodities are expected to be negligible, a default residue definition for 
enforcement  and  risk  assessment  in  ruminant  and  pig  matrices  can  be  proposed  as  parent 
desmedipham only. Validated analytical methods for enforcement of the proposed residue definition 
are available with an LOQ of 0.05 mg/kg but a confirmatory method is still required. Furthermore, 
MRLs  and  risk  assessment  values  for  the  relevant  commodities  in  ruminants  and  pigs  can  be 
established at the LOQ level. These MRLs can only be tentatively derived but, considering the low 
residue expected in animal tissue, for the time being new ruminant metabolism studies are desirable 
only. Nevertheless, EFSA highlights that, if in the future new uses leading to residues above the LOQ 
in  animal  commodities  will  be  granted,  the  proposed  formal  residue  definition  will  need  to  be 
reconsidered and more data on animal metabolism will be required. For poultry matrices, neither a 
residue  definition,  nor  MRLs  or  risk  assessment  values  are  necessary,  as  there  is  no  significant 
exposure of poultry to desmedipham residues. 
Chronic and acute consumer exposure resulting from the MRLs derived in the framework of this 
review  was  calculated  using  revision  2  of  the  EFSA  PRIMo.  The  highest  chronic  exposure 
represented 8.2 % of the ADI (British children) and the highest acute exposure amounted to 6.2 % of 
the ARfD (milk and milk products). 
RECOMMENDATIONS 
Based on the above assessment, EFSA does not  recommend inclusion of this active substance in 
Annex IV to Regulation (EC) No 396/2005. MRL recommendations were derived in compliance with 
the decision tree reported in Appendix D (see summary table). None of the MRL values listed in the 
table  are  recommended  for  inclusion  in  Annex  II  to  the  Regulation  as  they  are  not  sufficiently 
supported by data; they therefore require further consideration by risk managers (see summary table 
footnotes for details). In particular, certain tentative MRLs or existing EU MRLs still need to be 
confirmed by the following data: 
  a confirmatory method for the determination of desmedipham in fat, meat, liver and kidney (a 
new method will be provided in the framework of the AIR - January 2015); 
  a new representative study investigating primary crop metabolism in root and tuber vegetables 
(a new study will be provided in the framework of the AIR - January 2015); 
  a representative study investigating primary crop metabolism in leafy vegetables. 
If the above reported data gaps are not addressed in the future, Member States are recommended to 
withdraw or modify the relevant authorisations at national level. 
Minor deficiencies were also identified in the assessment but they are not expected to impact either on 
the validity of the MRLs derived or on the national authorisations. The following data are therefore 
considered desirable but not essential: 
  at least two trials in each zone complying with the northern and southern outdoor GAPs on 
sugar beet root, fodder beet root and beetroot, where residues are analysed according to the 
enforcement LOQ (0.01 mg/kg) (new trials will be provided in the framework of the AIR - 
January 2015); 
  at least two trials in each zone complying with the northern and southern outdoor GAPs on 
sugar  beet  tops,  fodder  beet  tops  and  beet  leaves  (chard),  where  residues  are  analysed 
according  to  the  enforcement  LOQ  (0.01  mg/kg)  (new  trials  will  be  provided  in  the 
framework of the AIR - January 2015); Review of the existing MRLs for desmedipham 
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  the missing information on the storage conditions of the samples from the concerned residue 
trials (this information will be provided in the framework of the AIR - January 2015); 
  new appropriate ruminant metabolism studies. 
SUMMARY TABLE 
Code 
number 
Commodity  Existing EU 
MRL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
Enforcement residue definition: desmedipham 
213010  Beetroot  0.05  0.05  Further consideration needed 
(1) 
252030  Beet leaves (chard)  0.05  0.05  Further consideration needed 
(1) 
900010  Sugar beet (root)  0.1  0.05  Further consideration needed 
(1) 
1011010  Swine muscle  -  0.05*  Further consideration needed 
(1) 
1011020  Swine fat (free of lean meat)  -  0.05*  Further consideration needed 
(1) 
1011030  Swine liver  -  0.05*  Further consideration needed 
(1) 
1011040  Swine kidney  -  0.05*  Further consideration needed 
(1) 
1012010  Bovine muscle  -  0.05*  Further consideration needed 
(1) 
1012020  Bovine fat  -  0.05*  Further consideration needed 
(1) 
1012030  Bovine liver  -  0.05*  Further consideration needed 
(1) 
1012040  Bovine kidney  -  0.05*  Further consideration needed 
(1) 
1013010  Sheep muscle  -  0.05*  Further consideration needed 
(1) 
1013020  Sheep fat  -  0.05*  Further consideration needed 
(1) 
1013030  Sheep liver  -  0.0.5*  Further consideration needed 
(1) 
1013040  Sheep kidney  -  0.05*  Further consideration needed 
(1) 
1014010  Goat muscle  -  0.05*  Further consideration needed 
(1) 
1014020  Goat fat  -  0.05*  Further consideration needed 
(1) 
1014030  Goat liver  -  0.0.5*  Further consideration needed 
(1) 
1014040  Goat kidney  -  0.05*  Further consideration needed 
(1) 
1020010  Cattle milk  -  0.05*  Further consideration needed 
(1) 
1020020  Sheep milk  -  0.05*  Further consideration needed 
(1) 
1020030  Goat milk  -  0.05*  Further consideration needed 
(1) 
-  Other products of plant and 
animal origin 
-  -  Further consideration needed 
(2) 
(*):   Indicates that the MRL is set at the limit of analytical quantification. 
(1):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified; no CXL is available (combination E-I in Appendix D). 
(2):  There are no relevant authorisations or import tolerances reported at EU level; no CXL is available. Either a specific 
LOQ or the default MRL of 0.01 mg/kg may be considered (combination A-I in Appendix D). 
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Appendix A – Good Agricultural Practices (GAPs) 
Conc. Unit
From 
BBCH
Until 
BBCH
Min. Max. Min. Max.
Beetroot
Beta vulgaris subsp. 
Vulgaris
NEU Outdoor PL, UK
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season.
Beet leaves (chard) Beta vulgaris  NEU Outdoor UK
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season.
Sugar beet Beta vulgaris NEU Outdoor
CZ, HU, PL, SK, 
UK
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season.
Fodder beet Beta vulgaris NEU Outdoor CZ, PL, SK, UK
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season.
n.a.: not applicable
Conc. Unit
From 
BBCH
Until 
BBCH
Min. Max. Min. Max.
Beetroot
Beta vulgaris subsp. 
Vulgaris
SEU Outdoor ES
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season. The following alternatives 
are authorised in Spain:
-1 x 0,48 kg as/ha
-2x0,24 kg as/ha
-3x0,16 kg as/ha
Sugar beet Beta vulgaris SEU Outdoor EL, ES, SL
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season. The following alternatives 
are authorised in Spain:
-1 x 0,48 kg as/ha
-2x0,24 kg as/ha
-3x0,16 kg as/ha
Fodder beet Beta vulgaris SEU Outdoor  ES, SL
Grassy and dicot weed 
species
EC 160,0 g/L Foliar treatment - spraying 10 18 1 3 160,00 g a.i./ha n.a.
Max application rate of 
desmedipham is 0.48 kg as/ha per 
season. The following alternatives 
are authorised in Spain:
-1 x 0,48 kg as/ha
-2x0,24 kg as/ha
-3x0,16 kg as/ha
n.a.: not applicable
Critical Outdoor GAPs for Northern Europe
Crop
Region
Outdoor/ 
Indoor
Member state or 
Country
Pests controlled
Formulation Application Application rate PHI  or 
wiaiting 
period 
(days)
Comments (max. 250 charachters)
Common name Scientific name Type
Content
Method
Growth stage Number Interval (days)
Min. rate Max. rate Rate Unit
Critical Outdoor GAPs for Southern Europe
Crop
Region
Outdoor/ 
Indoor
Member state or 
Country
Pests controlled
Formulation Application
Comments (max. 250 charachters)
Common name Scientific name Type
Content
Method
Growth stage Number Interval (days)
Min. rate Max. rate Rate Unit
Application rate PHI  or 
wiaiting 
period 
(days)
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Appendix B – Pesticide Residues Intake Model (PRIMo) 
Status of the active substance: Included Code no.
LOQ (mg/kg bw): proposed LOQ:
ADI (mg/kg bw/day): 0.03 ARfD (mg/kg bw): 0.1
Source of ADI: COM Source of ARfD: COM
Year of evaluation: 2004 Year of evaluation: 2004
8
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
8.2 UK Infant  6.5 1.7 0.0 Bovine: Liver
7.3 UK Toddler 3.8 3.4 0.0 Bovine: Liver
6.9 FR toddler 6.6 0.2 0.1 Swine: Meat
5.4 NL child 4.9 0.3 0.2 Bovine: Meat
4.4 FR infant 4.3 0.1 0.0 Swine: Meat
2.6 ES child 2.1 0.2 0.2 Swine: Meat
2.5 DE child 2.4 0.1 0.1 Bovine: Meat
2.1 DK child 2.1 0.0 0.0 Beetroot
2.1 SE  general population 90th percentile 2.1 0.0 0.0 Beet leaves (chard)
1.4 NL general 1.1 0.2 0.1 Bovine: Meat
1.3 WHO regional European diet  0.8 0.2 0.2 Bovine: Meat
1.2 UK vegetarian 0.6 0.5 0.0 Beetroot
1.2 UK Adult  0.7 0.5 0.0 Bovine: Liver
1.1 ES adult 0.8 0.1 0.1 Swine: Meat
1.1 WHO Cluster diet B  0.5 0.1 0.1 Swine: Meat
1.0 WHO Cluster diet F  0.7 0.2 0.1 Bovine: Meat
1.0 WHO cluster diet D 0.8 0.1 0.0 Swine: Meat
1.0 DK adult 0.9 0.1 0.0 Bovine: Liver
1.0 FI  adult 0.9 0.0 FRUIT (FRESH OR FROZEN)
0.9 LT adult 0.7 0.2 0.0 Bovine: Meat
0.8 WHO cluster diet E 0.5 0.1 0.1 Swine: Meat
0.7 IE adult 0.5 0.1 0.1 Swine: Meat
0.6 FR all population 0.4 0.1 0.0 Swine: Meat
0.0 PL  general population 0.0 0.0 FRUIT (FRESH OR FROZEN)
0.0 IT adult 0.0 0.0 FRUIT (FRESH OR FROZEN)
0.0 IT kids/toddler 0.0 FRUIT (FRESH OR FROZEN)
PT General population FRUIT (FRESH OR FROZEN)
Milk and cream, 
Milk and cream, 
Beetroot
Beet leaves (chard)
Beet leaves (chard)
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Sugar beet (root)
Sugar beet (root)
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Milk and cream, 
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Desmedipham is unlikely to present a public health concern.
Desmedipham
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Commodity / 
group of commodities
Commodity / 
group of commodities
Milk and cream, 
Sugar beet (root)
Sugar beet (root)
Milk and cream, 
Bovine: Meat
Swine: Meat
Bovine: Meat
Bovine: Meat
Swine: Meat
Bovine: Liver
Beetroot
Swine: Meat
Swine: Meat
Milk and cream, 
Bovine: Meat
Bovine: Meat
Swine: Meat
Bovine: Meat
Bovine: Meat
Beetroot
Swine: Meat
Bovine: Meat
FRUIT (FRESH OR FROZEN) FRUIT (FRESH OR FROZEN)
FRUIT (FRESH OR FROZEN)
Bovine: Meat
Bovine: Meat
Beet leaves (chard)
Beetroot
Prepare workbook for refined 
calculations
Undo refined calculations
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The acute risk assessment is based on the ARfD.
--- --- --- ---
IESTI 1 *) **) IESTI 2 *) **) IESTI 1 *) **) IESTI 2 *) **)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
6.2 Milk and milk  0.05 / - 6.2 Milk and milk  0.05 / - 1.3 Sugar beet (root) 0.05 / - 1.3 Sugar beet (root) 0.05 / -
3.2 Sugar beet (root) 0.05 / - 3.2 Sugar beet (root) 0.05 / - 0.9 Milk and milk  0.05 / - 0.9 Milk and milk products: Cattle 0.05 / -
2.2 Beetroot 0.05 / - 1.6 Beetroot 0.05 / - 0.7 Beetroot 0.05 / - 0.5 Beetroot 0.05 / -
1.2 Milk and milk  0.05 / - 1.2 Milk and milk  0.05 / - 0.4 Beet leaves (chard) 0.05 / - 0.3 Milk and milk products: Goat 0.05 / -
0.9 Beet leaves (chard) 0.05 / - 0.7 Beet leaves  0.05 / - 0.3 Milk and milk  0.05 / - 0.3 Beet leaves (chard) 0.05 / -
No of critical MRLs (IESTI 1) --- No of critical MRLs (IESTI 2) ---
--- ---
***) ***)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
For processed commodities, no exceedance of the ARfD/ADI was identified.
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*) The results of the IESTI calculations are reported for at least 5 commodities. If the ARfD is exceeded for more than 5 commodities, all IESTI values > 90% of ARfD are reported. 
**) pTMRL: provisional temporary MRL
***) pTMRL: provisional temporary MRL for unprocessed commodity
No exceedance of the ARfD/ADI was identified for any unprocessed commodity. 
 
Acute risk assessment /children - refined calculations Acute risk assessment / adults / general population - refined calculations
Conclusion:
For Desmedipham IESTI 1 and IESTI 2 were calculated for food commodities for which pTMRLs were submitted and for which consumption data are available.
In the IESTI 1 calculation, the variability factors were 10, 7 or 5 (according to JMPR manual 2002), for lettuce a variability factor of 5 was used. 
In the IESTI 2 calculations, the variability factors of 10 and 7 were replaced by 5. For lettuce the calculation was performed with a variabilty factor of 3.  
No of commodities for which ARfD/ADI is 
exceeded (IESTI 2):
For each commodity the calculation is based on the highest reported MS consumption per kg bw and the corresponding unit weight from the MS with the critical consumption. If no data on the unit weight was available from that MS an average 
European unit weight was used for the IESTI calculation. 
No of commodities for which 
ARfD/ADI is exceeded:
No of commodities for which ARfD/ADI 
is exceeded:
Threshold MRL is the  calculated residue level which would leads to an exposure equivalent to 100 % of the ARfD.  
No of commodities for which ARfD/ADI 
is exceeded (IESTI 1):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 2):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 1):
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Appendix C – Existing EU maximum residue limits (MRLs) 
(Pesticides - Web Version - EU MRLs (File created on 24/10/2011 11:12) 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
100000  1. FRUIT FRESH OR 
FROZEN; NUTS  0,05* 
110000  (i) Citrus fruit  0,05* 
110010  Grapefruit (Shaddocks, 
pomelos, sweeties, tangelo, 
ugli and other hybrids)  0,05* 
110020  Oranges (Bergamot, bitter 
orange, chinotto and other 
hybrids)  0,05* 
110030  Lemons (Citron, lemon )  0,05* 
110040  Limes  0,05* 
110050  Mandarins (Clementine, 
tangerine and other hybrids)  0,05* 
110990  Others  0,05* 
120000  (ii) Tree nuts (shelled or 
unshelled)  0,05* 
120010  Almonds  0,05* 
120020  Brazil nuts  0,05* 
120030  Cashew nuts  0,05* 
120040  Chestnuts  0,05* 
120050  Coconuts  0,05* 
120060  Hazelnuts (Filbert)  0,05* 
120070  Macadamia  0,05* 
120080  Pecans  0,05* 
120090  Pine nuts  0,05* 
120100  Pistachios  0,05* 
120110  Walnuts  0,05* 
120990  Others  0,05* 
130000  (iii) Pome fruit  0,05* 
130010  Apples (Crab apple)  0,05* 
130020  Pears (Oriental pear)  0,05* 
130030  Quinces  0,05* 
130040  Medlar  0,05* 
130050  Loquat  0,05* 
130990  Others  0,05* 
140000  (iv) Stone fruit  0,05* 
140010  Apricots  0,05* 
140020  Cherries (sweet cherries, sour 
cherries)  0,05* 
140030  Peaches (Nectarines and 
similar hybrids)  0,05* 
140040  Plums (Damson, greengage, 
mirabelle)  0,05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
140990  Others  0,05* 
150000  (v) Berries & small fruit  0,05* 
151000  (a) Table and wine grapes  0,05* 
151010  Table grapes  0,05* 
151020  Wine grapes  0,05* 
152000  (b) Strawberries  0,05* 
153000  (c) Cane fruit  0,05* 
153010  Blackberries  0,05* 
153020  Dewberries (Loganberries, 
Boysenberries, and 
cloudberries)  0,05* 
153030  Raspberries (Wineberries )  0,05* 
153990  Others  0,05* 
154000  (d) Other small fruit & berries  0,05* 
154010  Blueberries (Bilberries 
cowberries (red bilberries))  0,05* 
154020  Cranberries  0,05* 
154030  Currants (red, black and white)  0,05* 
154040  Gooseberries (Including 
hybrids with other ribes 
species)  0,05* 
154050  Rose hips  0,05* 
154060  Mulberries (arbutus berry)  0,05* 
154070  Azarole (mediteranean 
medlar)  0,05* 
154080  Elderberries (Black 
chokeberry (appleberry), 
mountain ash, azarole, 
buckthorn (sea sallowthorn), 
hawthorn, service berries, and 
other treeberries)  0,05* 
154990  Others  0,05* 
160000  (vi) Miscellaneous fruit  0,05* 
161000  (a) Edible peel  0,05* 
161010  Dates  0,05* 
161020  Figs  0,05* 
161030  Table olives  0,05* 
161040  Kumquats (Marumi 
kumquats, nagami kumquats)  0,05* 
161050  Carambola (Bilimbi)  0,05* 
161060  Persimmon  0,05* 
161070  Jambolan (java plum) (Java 
apple (water apple), pomerac,  0,05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
rose apple, Brazilean cherry 
(grumichama), Surinam 
cherry) 
161990  Others  0,05* 
162000  (b) Inedible peel, small  0,05* 
162010  Kiwi  0,05* 
162020  Lychee (Litchi) (Pulasan, 
rambutan (hairy litchi))  0,05* 
162030  Passion fruit  0,05* 
162040  Prickly pear (cactus fruit)  0,05* 
162050  Star apple  0,05* 
162060  American persimmon 
(Virginia kaki) (Black sapote, 
white sapote, green sapote, 
canistel (yellow sapote), and 
mammey sapote)  0,05* 
162990  Others  0,05* 
163000  (c) Inedible peel, large  0,05* 
163010  Avocados  0,05* 
163020  Bananas (Dwarf banana, 
plantain, apple banana)  0,05* 
163030  Mangoes  0,05* 
163040  Papaya  0,05* 
163050  Pomegranate  0,05* 
163060  Cherimoya (Custard apple, 
sugar apple (sweetsop) , llama 
and other medium sized 
Annonaceae)  0,05* 
163070  Guava  0,05* 
163080  Pineapples  0,05* 
163090  Bread fruit (Jackfruit)  0,05* 
163100  Durian  0,05* 
163110  Soursop (guanabana)  0,05* 
163990  Others  0,05* 
200000  2. VEGETABLES FRESH 
OR FROZEN  0,05* 
210000  (i) Root and tuber vegetables  0,05* 
211000  (a) Potatoes  0,05* 
212000  (b) Tropical root and tuber 
vegetables  0,05* 
212010  Cassava (Dasheen, eddoe 
(Japanese taro), tannia)  0,05* 
212020  Sweet potatoes  0,05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
212030  Yams (Potato bean (yam 
bean), Mexican yam bean)  0,05* 
212040  Arrowroot  0,05* 
212990  Others  0,05* 
213000  (c) Other root and tuber 
vegetables except sugar beet  0,05* 
213010  Beetroot  0,05* 
213020  Carrots  0,05* 
213030  Celeriac  0,05* 
213040  Horseradish  0,05* 
213050  Jerusalem artichokes  0,05* 
213060  Parsnips  0,05* 
213070  Parsley root  0,05* 
213080  Radishes (Black radish, 
Japanese radish, small radish 
and similar varieties)  0,05* 
213090  Salsify (Scorzonera, Spanish 
salsify (Spanish oysterplant))  0,05* 
213100  Swedes  0,05* 
213110  Turnips  0,05* 
213990  Others  0,05* 
220000  (ii) Bulb vegetables  0,05* 
220010  Garlic  0,05* 
220020  Onions (Silverskin onions)  0,05* 
220030  Shallots  0,05* 
220040  Spring onions (Welsh onion 
and similar varieties)  0,05* 
220990  Others  0,05* 
230000  (iii) Fruiting vegetables  0,05* 
231000  (a) Solanacea  0,05* 
231010  Tomatoes (Cherry tomatoes, )  0,05* 
231020  Peppers (Chilli peppers)  0,05* 
231030  Aubergines (egg plants) 
(Pepino)  0,05* 
231040  Okra, lady’s fingers  0,05* 
231990  Others  0,05* 
232000  (b) Cucurbits - edible peel  0,05* 
232010  Cucumbers  0,05* 
232020  Gherkins  0,05* 
232030  Courgettes (Summer squash, 
marrow (patisson))  0,05* 
232990  Others  0,05* 
233000  (c) Cucurbits-inedible peel  0,05* Review of the existing MRLs for desmedipham 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
233010  Melons (Kiwano )  0,05* 
233020  Pumpkins (Winter squash)  0,05* 
233030  Watermelons  0,05* 
233990  Others  0,05* 
234000  (d) Sweet corn  0,05* 
239000  (e) Other fruiting vegetables  0,05* 
240000  (iv) Brassica vegetables  0,05* 
241000  (a) Flowering brassica  0,05* 
241010  Broccoli (Calabrese, Chinese 
broccoli, Broccoli raab)  0,05* 
241020  Cauliflower  0,05* 
241990  Others  0,05* 
242000  (b) Head brassica  0,05* 
242010  Brussels sprouts  0,05* 
242020  Head cabbage (Pointed head 
cabbage, red cabbage, savoy 
cabbage, white cabbage)  0,05* 
242990  Others  0,05* 
243000  (c) Leafy brassica  0,05* 
243010  Chinese cabbage (Indian 
(Chinese) mustard, pak choi, 
Chinese flat cabbage (tai goo 
choi), peking cabbage (pe-
tsai), cow cabbage)  0,05* 
243020  Kale (Borecole (curly kale), 
collards)  0,05* 
243990  Others  0,05* 
244000  (d) Kohlrabi  0,05* 
250000  (v) Leaf vegetables & fresh 
herbs  0,05* 
251000  (a) Lettuce and other salad 
plants including Brassicacea  0,05* 
251010  Lamb´s lettuce (Italian 
cornsalad)  0,05* 
251020  Lettuce (Head lettuce, lollo 
rosso (cutting lettuce), iceberg 
lettuce, romaine (cos) lettuce)  0,05* 
251030  Scarole (broad-leaf endive) 
(Wild chicory, red-leaved 
chicory, radicchio, curld leave 
endive, sugar loaf)  0,05* 
251040  Cress  0,05* 
251050  Land cress  0,05* 
251060  Rocket, Rucola (Wild rocket)  0,05* 
251070  Red mustard  0,05* 
251080  Leaves and sprouts of Brassica 
spp (Mizuna)  0,05* 
251990  Others  0,05* 
252000  (b) Spinach & similar (leaves)  0,05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
252010  Spinach (New Zealand 
spinach, turnip greens (turnip 
tops))  0,05* 
252020  Purslane (Winter purslane 
(miner’s lettuce), garden 
purslane, common purslane, 
sorrel, glassworth)  0,05* 
252030  Beet leaves (chard) (Leaves of 
beetroot)  0,05* 
252990  Others  0,05* 
253000  (c) Vine leaves (grape leaves)  0,05* 
254000  (d) Water cress  0,05* 
255000  (e) Witloof  0,05* 
256000  (f) Herbs  0,05* 
256010  Chervil  0,05* 
256020  Chives  0,05* 
256030  Celery leaves (fennel leaves , 
Coriander leaves, dill leaves, 
Caraway leaves, lovage, 
angelica, sweet cisely and 
other Apiacea)  0,05* 
256040  Parsley  0,05* 
256050  Sage (Winter savory, summer 
savory, )  0,05* 
256060  Rosemary  0,05* 
256070  Thyme ( marjoram, oregano)  0,05* 
256080  Basil (Balm leaves, mint, 
peppermint)  0,05* 
256090  Bay leaves (laurel)  0,05* 
256100  Tarragon (Hyssop)  0,05* 
256990  Others  0,05* 
260000  (vi) Legume vegetables (fresh)  0,05* 
260010  Beans (with pods) (Green 
bean (french beans, snap 
beans), scarlet runner bean, 
slicing bean, yardlong beans)  0,05* 
260020  Beans (without pods) (Broad 
beans, Flageolets, jack bean, 
lima bean, cowpea)  0,05* 
260030  Peas (with pods) (Mangetout 
(sugar peas))  0,05* 
260040  Peas (without pods) (Garden 
pea, green pea, chickpea)  0,05* 
260050  Lentils  0,05* 
260990  Others  0,05* 
270000  (vii) Stem vegetables (fresh)  0,05* 
270010  Asparagus  0,05* 
270020  Cardoons  0,05* 
270030  Celery  0,05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
270040  Fennel  0,05* 
270050  Globe artichokes  0,05* 
270060  Leek  0,05* 
270070  Rhubarb  0,05* 
270080  Bamboo shoots  0,05* 
270090  Palm hearts  0,05* 
270990  Others  0,05* 
280000  (viii) Fungi  0,05* 
280010  Cultivated (Common 
mushroom, Oyster mushroom, 
Shi-take)  0,05* 
280020  Wild (Chanterelle, Truffle, 
Morel ,)  0,05* 
280990  Others  0,05* 
290000  (ix) Sea weeds  0,05* 
300000  3. PULSES, DRY  0,05* 
300010  Beans (Broad beans, navy 
beans, flageolets, jack beans, 
lima beans, field beans, 
cowpeas)  0,05* 
300020  Lentils  0,05* 
300030  Peas (Chickpeas, field peas, 
chickling vetch)  0,05* 
300040  Lupins  0,05* 
300990  Others  0,05* 
400000  4. OILSEEDS AND 
OILFRUITS    
401000  (i) Oilseeds  0,1* 
401010  Linseed  0,1* 
401020  Peanuts  0,1* 
401030  Poppy seed  0,1* 
401040  Sesame seed  0,1* 
401050  Sunflower seed  0,1* 
401060  Rape seed (Bird rapeseed, 
turnip rape)  0,1* 
401070  Soya bean  0,1* 
401080  Mustard seed  0,1* 
401090  Cotton seed  0,1* 
401100  Pumpkin seeds  0,1* 
401110  Safflower  0,1* 
401120  Borage  0,1* 
401130  Gold of pleasure  0,1* 
401140  Hempseed  0,1* 
401150  Castor bean  0,1* 
401990  Others  0,1* 
402000  (ii) Oilfruits    
402010  Olives for oil production  0,05* 
402020  Palm nuts (palmoil kernels)  0,1* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
402030  Palmfruit  0,1* 
402040  Kapok  0,1* 
402990  Others  0,1* 
500000  5. CEREALS  0,05* 
500010  Barley  0,05* 
500020  Buckwheat  0,05* 
500030  Maize  0,05* 
500040  Millet (Foxtail millet, teff)  0,05* 
500050  Oats  0,05* 
500060  Rice  0,05* 
500070  Rye  0,05* 
500080  Sorghum  0,05* 
500090  Wheat (Spelt Triticale)  0,05* 
500990  Others  0,05* 
600000  6. TEA, COFFEE, HERBAL 
INFUSIONS AND COCOA  0,1* 
610000  (i) Tea (dried leaves and stalks, 
fermented or otherwise of 
Camellia sinensis)  0,1* 
620000  (ii) Coffee beans  0,1* 
630000  (iii) Herbal infusions (dried)  0,1* 
631000  (a) Flowers  0,1* 
631010  Camomille flowers  0,1* 
631020  Hybiscus flowers  0,1* 
631030  Rose petals  0,1* 
631040  Jasmine flowers  0,1* 
631050  Lime (linden)  0,1* 
631990  Others  0,1* 
632000  (b) Leaves  0,1* 
632010  Strawberry leaves  0,1* 
632020  Rooibos leaves  0,1* 
632030  Maté  0,1* 
632990  Others  0,1* 
633000  (c) Roots  0,1* 
633010  Valerian root  0,1* 
633020  Ginseng root  0,1* 
633990  Others  0,1* 
639000  (d) Other herbal infusions  0,1* 
640000  (iv) Cocoa (fermented beans)  0,1* 
650000  (v) Carob (st johns bread)  0,1* 
700000  7. HOPS (dried) , including 
hop pellets and unconcentrated 
powder  0,1* 
800000  8. SPICES  0,1* 
810000  (i) Seeds  0,1* 
810010  Anise  0,1* 
810020  Black caraway  0,1* 
810030  Celery seed (Lovage seed)  0,1* Review of the existing MRLs for desmedipham 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
810040  Coriander seed  0,1* 
810050  Cumin seed  0,1* 
810060  Dill seed  0,1* 
810070  Fennel seed  0,1* 
810080  Fenugreek  0,1* 
810090  Nutmeg  0,1* 
810990  Others  0,1* 
820000  (ii) Fruits and berries  0,1* 
820010  Allspice  0,1* 
820020  Anise pepper (Japan pepper)  0,1* 
820030  Caraway  0,1* 
820040  Cardamom  0,1* 
820050  Juniper berries  0,1* 
820060  Pepper, black and white (Long 
pepper, pink pepper)  0,1* 
820070  Vanilla pods  0,1* 
820080  Tamarind  0,1* 
820990  Others  0,1* 
830000  (iii) Bark  0,1* 
830010  Cinnamon (Cassia )  0,1* 
830990  Others  0,1* 
840000  (iv) Roots or rhizome  0,1* 
840010  Liquorice  0,1* 
840020  Ginger  0,1* 
840030  Turmeric (Curcuma)  0,1* 
840040  Horseradish  0,1* 
840990  Others  0,1* 
850000  (v) Buds  0,1* 
850010  Cloves  0,1* 
850020  Capers  0,1* 
850990  Others  0,1* 
860000  (vi) Flower stigma  0,1* 
860010  Saffron  0,1* 
860990  Others  0,1* 
870000  (vii) Aril  0,1* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
870010  Mace  0,1* 
870990  Others  0,1* 
900000  9. SUGAR PLANTS    
900010  Sugar beet (root)  0,1 
900020  Sugar cane  0,05* 
900030  Chicory roots  0,05* 
900990  Others  0,05* 
1000000  10. PRODUCTS OF 
ANIMAL ORIGIN-
TERRESTRIAL ANIMALS 
 
1010000  (i) Meat, preparations of meat, 
offals, blood, animal fats fresh 
chilled or frozen, salted, in 
brine, dried or smoked or 
processed as flours or meals 
other processed products such 
as sausages and food 
preparations based on these 
 
1011000  (a) Swine   
1011010  Meat   
1011020  Fat free of lean meat   
1011030  Liver   
1011040  Kidney   
1011050  Edible offal   
1011990  Others   
1012000  (b) Bovine   
1012010  Meat   
1012020  Fat   
1012030  Liver   
1012040  Kidney   
1012050  Edible offal   
1012990  Others   
1013000  (c) Sheep   
1013010  Meat   
1013020  Fat   
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
1013030  Liver   
1013040  Kidney   
1013050  Edible offal   
1013990  Others   
1014000  (d) Goat   
1014010  Meat   
1014020  Fat   
1014030  Liver   
1014040  Kidney   
1014050  Edible offal   
1014990  Others   
1015000  (e) Horses, asses, mules or 
hinnies 
 
1015010  Meat   
1015020  Fat   
1015030  Liver   
1015040  Kidney   
1015050  Edible offal   
1015990  Others   
1016000  (f) Poultry -chicken, geese, 
duck, turkey and Guinea fowl-
, ostrich, pigeon 
 
1016010  Meat   
1016020  Fat   
1016030  Liver   
1016040  Kidney   
1016050  Edible offal   
1016990  Others   
1017000  (g) Other farm animals 
(Rabbit, Kangaroo) 
 
1017010  Meat   
1017020  Fat   
1017030  Liver   
1017040  Kidney   
1017050  Edible offal   
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
desmedipham 
1017990  Others   
1020000  (ii) Milk and cream, not 
concentrated, nor containing 
added sugar or sweetening 
matter, butter and other fats 
derived from milk, cheese and 
curd 
 
1020010  Cattle   
1020020  Sheep   
1020030  Goat   
1020040  Horse   
1020990  Others   
1030000  (iii) Birds’ eggs, fresh 
preserved or cooked Shelled 
eggs and egg yolks fresh, 
dried, cooked by steaming or 
boiling in water, moulded, 
frozen or otherwise preserved 
whether or not containing 
added sugar or sweetening 
matter 
 
1030010  Chicken   
1030020  Duck   
1030030  Goose   
1030040  Quail   
1030990  Others   
1040000  (iv) Honey (Royal jelly, 
pollen) 
 
1050000  (v) Amphibians and reptiles 
(Frog legs, crocodiles) 
 
1060000  (vi) Snails   
1070000  (vii) Other terrestrial animal 
products 
 
(*) Indicates lower limit of analytical determination 
(a): Table footnote Review of the existing MRLs for desmedipham 
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Appendix D – Decision tree for deriving MRL recommendations  
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No
Yes
(I)
Maintain EU 
recommendation 
indicating that no 
CXL is available.
(II)
Maintain EU 
recommendation 
indicating CXL is 
not compatible.
(III)
Maintain EU 
recommendation 
indicating that 
CXL is covered.
(IV)
Maintain EU 
recommendation; 
higher CXL is not 
safe for consumer.
(V)
Maintain current 
CXL or EU 
recommendation?
(VI)
Maintain EU 
recommendation; 
higher CXL is not 
safe for consumer.
(VII)
CXL is 
recommended; EU 
recommendation 
is covered as well.
CXL available?
RD 
comparable?
CXL
supported by 
data?
Risk identified? Risk identified?
Codex median/
highest residues 
are included in the 
RA.
CXL is included in 
the RA.
Input values for 
the RA remain 
unchanged.
Input values for 
the RA remain 
unchanged.
No Yes
Yes
No
Yes
No
Yes No Yes No
Recommendations with consideration of the existing CXL
Comparison of the EU recommendation with the existing CXL
Consumer risk assessment with consideration of the existing CXL
Input values for 
the RA remain 
unchanged.
CXL higher?
Result EU 
assessment
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Appendix E – List of metabolites and related structural formula 
Common name  IUPAC name  Structural formula 
desmedipham  ethyl 3-phenylcarbamoyloxycarbanilate  CH3 NH NH
O O
O O
 
EHPC  ethyl (3-hydroxyphenyl)carbamate  CH3 NH
O
O O H
 
m-aminophenol  3-aminophenol  NH2
OH  
3-
acetamidophenol  
N-(3-hydroxyphenyl)acetamide  NH
O
CH3 O H
 
4-
acetamidophenol 
N-(4-hydroxyphenyl)acetamide  NH
O
CH3
O H  
4-aminophenol  4-aminophenol  NH2
O H  
N-(phenyl)methyl 
carbamate 
methyl phenylcarbamate  NH
O
O
CH3
 Review of the existing MRLs for desmedipham 
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ABBREVIATIONS 
a.s.  active substance 
ADI  acceptable daily intake 
ARfD  acute reference dose 
BBCH  growth stages of mono- and dicotyledonous plants 
bw 
CEN 
body weight 
European  Committee  for  Standardization  (Comité  Européen  de 
Normalisation) 
CF  conversion  factor  for  enforcement  residue  definition  to  risk  assessment 
residue definition 
CXL  codex maximum residue limit 
d  day 
DAR  Draft Assessment Report (prepared under Council Directive 91/414/EEC) 
DAT  days after treatment 
DM  dry matter 
DT90  period required for 90 percent dissipation (define method of estimation) 
EC  European Commission 
EFSA  European Food Safety Authority 
EHPC 
EPC 
N-(3-hydroxy phenyl) ethyl carbamate 
ethyl 3-[U-
14C] phenylcarbomoyloxyphenylcarbamate 
eq  residue expressed as a.s. equivalent 
EU 
EURL 
European Union 
EU Reference Laboratories (former CRLs) 
FAO  Food and Agriculture Organization of the United Nations 
GAP  good agricultural practice 
GC-MS  gas chromatography with mass spectrometry 
Ha 
HPLC-UVD 
Hectare 
high performance liquid chromatography with ultra-violet detector Review of the existing MRLs for desmedipham 
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ILV  independent laboratory validation 
ISO  International Organisation for Standardization 
IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint FAO/WHO Meeting on Pesticide Residues 
LC-MS/MS  liquid chromatography with tandem mass spectrometry 
LOQ  limit of quantification  
MRL  maximum residue limit 
MS  Member States 
NEU 
OECD 
northern European Union 
Organisation for Economic Co-operation and Development 
PC  ethyl 3-phenylcarbomoyloxy-[U-
14C] phenylcarbamate 
PHI  pre-harvest interval 
Pow  partition coefficient n-octanol/water 
PROFile  (EFSA) Pesticide Residue Overview File 
PRIMo  (EFSA) Pesticide Residues Intake Model 
RMS  rapporteur Member State 
SEU  southern European Union 
TRR  total radioactive residue 
WHO  World Health Organization 
 